Population
"hammerhead" RNA self-cleaving domain assembled from two RNA molecules
Design
Preclinical
Authors
Loading...
Substrate structure may dictate hammerhead efficiency in vitro; leaves open relevance to therapeutic ribozyme applications.
The secondary structure of substrate RNA can be a major determinant of hammerhead catalytic efficiency, as substrates with high Km values form nonreactive aggregates.
Fedor et al. (1990) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: